A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.

Adv Ther · 2025 · PMC12313740 · PMID 40493333

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Nocturnal IOP was nominally significant at the 0.10 level in favor of sepetaprost over latanoprost; while these results are exploratory, the 90% CI provides some support for the observed numerical differences.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.